当前位置: 首页 >> 检索结果
241. Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.
作者: Lukas Schlager.;Michaela Loiskandl.;Daniel Aletaha.;Helga Radner.
来源: Rheumatology (Oxford). 2020年59卷2期324-334页
To systematically review possible predictors of successful discontinuation of biologic or targeted synthetic DMARDs (b/tsDMARDs) in RA patients in remission or low disease activity.
242. The diagnostic performance of dual energy CT for diagnosing gout: a systematic literature review and meta-analysis.
作者: Mihaela Gamala.;Johannes W G Jacobs.;Jaap M van Laar.
来源: Rheumatology (Oxford). 2019年58卷12期2117-2121页
This study aimed to assess the utility of dual energy CT (DECT) for diagnosing gout.
243. Performance of magnetic resonance imaging in the diagnosis of axial spondyloarthritis: a systematic literature review.
作者: Alexis Jones.;Timothy J P Bray.;Peter Mandl.;Margaret A Hall-Craggs.;Helena Marzo-Ortega.;Pedro M Machado.
来源: Rheumatology (Oxford). 2019年58卷11期1955-1965页
To summarize the evidence on the performance of MRI for the diagnosis of axial SpA.
244. A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.
作者: Katie Bechman.;Sujith Subesinghe.;Sam Norton.;Fabiola Atzeni.;Massimo Galli.;Andrew P Cope.;Kevin L Winthrop.;James B Galloway.
来源: Rheumatology (Oxford). 2019年58卷10期1755-1766页
To evaluate the risk of serious infection (SI) and herpes zoster (HZ) in rheumatoid arthritis patients receiving JAK inhibitors.
245. The role of vitamin D testing and replacement in fibromyalgia: a systematic literature review.
作者: Shawn D Ellis.;Sam T Kelly.;Jonathan H Shurlock.;Alastair L N Hepburn.
来源: BMC Rheumatol. 2018年2卷28页
Fibromyalgia is a debilitating condition, characterized by extensive muscular pain and fatigue. Vitamin D is essential for overall health, with ubiquitous involvement in various inflammatory and pain pathways. Little is known about its role in fibromyalgia. We performed a systematic literature review to determine if vitamin D contributes to the pathology and disability of patients with fibromyalgia, and to assess the role of vitamin D supplementation in disease management.
246. How do patients with systemic autoimmune rheumatic disease perceive the use of their medications: a systematic review and thematic synthesis of qualitative research.247. Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set.
作者: Matthew J Page.;Denise A O'Connor.;Mary Malek.;Romi Haas.;Dorcas Beaton.;Hsiaomin Huang.;Sofia Ramiro.;Pamela Richards.;Marieke J H Voshaar.;Beverley Shea.;Arianne P Verhagen.;Samuel L Whittle.;Danielle A van der Windt.;Joel J Gagnier.;Rachelle Buchbinder.; .
来源: Rheumatology (Oxford). 2019年
To describe the experiences (including symptoms and perceived impacts on daily living) of people with a shoulder disorder.
248. Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis.
作者: Martijn J H Doeleman.;Erik M van Maarseveen.;Joost F Swart.
来源: Rheumatology (Oxford). 2019年58卷10期1839-1849页
The clinical impact of anti-drug antibodies (ADAbs) in paediatric patients with JIA remains unknown. This systematic review and meta-analysis aimed to summarize the prevalence of ADAbs in JIA studies; investigate the effect of ADAbs on treatment efficacy and adverse events; and explore the effect of immunosuppressive therapy on antibody formation.
249. Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature.
作者: Laurent Arnaud.;Pierre Edouard Gavand.;Rheinardt Voll.;Andreas Schwarting.;François Maurier.;Gilles Blaison.;Nadine Magy-Bertrand.;Jean-Loup Pennaforte.;Hans-Harmut Peter.;Pierre Kieffer.;Bernard Bonnotte.;Vincent Poindron.;Christoph Fiehn.;Hannes Lorenz.;Zahir Amoura.;Jean Sibilia.;Thierry Martin.
来源: Rheumatology (Oxford). 2019年58卷6期987-996页
Fatigue is reported in up to 90% of patients with SLE. This study was conducted to identify the determinants associated with fatigue in a large cohort of patients with SLE, as well as to provide a systematic review of the literature.
250. Psoriatic arthritis screening: a systematic review and meta-analysis.
作者: Nicolas Iragorri.;Glen Hazlewood.;Braden Manns.;Vishva Danthurebandara.;Eldon Spackman.
来源: Rheumatology (Oxford). 2019年58卷4期692-707页
To systematically review the accuracy and characteristics of different questionnaire-based PsA screening tools.
251. Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature.
作者: Piero Ruscitti.;Luigi Sinigaglia.;Massimiliano Cazzato.;Rosa Daniela Grembiale.;Giovanni Triolo.;Ennio Lubrano.;Carlomaurizio Montecucco.;Roberto Giacomelli.
来源: Rheumatology (Oxford). 2018年57卷57 Suppl 7期vii23-vii31页
To review the available evidence concerning the possibility of discontinuing and/or tapering the dosage of TNF inhibitors (TNFi) in RA patients experiencing clinical remission or low disease activity.
252. Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus.
作者: Alessandra Bortoluzzi.;Guido Valesini.;Salvatore D'Angelo.;Bruno Frediani.;Laura Bazzichi.;Antonella Afeltra.;Giuseppe Paolazzi.;Andrea Doria.;Pier Luigi Meroni.;Marcello Govoni.
来源: Rheumatology (Oxford). 2018年57卷57 Suppl 7期vii32-vii41页
To establish clinical consensus for the optimal placement of TNF inhibitor (TNFi) in DMARDs-naïve RA patients.
253. Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.
作者: Yesim Ozguler.;Pietro Leccese.;Robin Christensen.;Sinem Nihal Esatoglu.;Dongsik Bang.;Bahram Bodaghi.;Aykut Ferhat Çelik.;Farida Fortune.;Julien Gaudric.;Ahmet Gul.;Ina Kötter.;Alfred Mahr.;Robert J Moots.;Jutta Richter.;David Saadoun.;Carlo Salvarani.;Francesco Scuderi.;Petros P Sfikakis.;Aksel Siva.;Miles Stanford.;Ilknur Tugal-Tutkun.;Richard West.;Sebahattin Yurdakul.;Ignazio Olivieri.;Hasan Yazici.;Gulen Hatemi.
来源: Rheumatology (Oxford). 2018年57卷12期2200-2212页
To assess the efficacy and safety of treatment modalities for major organ involvement of Behçet's syndrome (BS), in order to inform the update of the EULAR recommendations for the management of BS.
254. Simultaneous occurrence of ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: a systematic review.
作者: Jonneke S Kuperus.;Job F Waalwijk.;Elizabeth A Regan.;Irene E van der Horst-Bruinsma.;F Cumhur Oner.;Pim A de Jong.;Jorrit-Jan Verlaan.
来源: Rheumatology (Oxford). 2018年57卷12期2120-2128页
AS and DISH are both spinal ankylosing conditions with a 4-fold increased risk of spinal fractures. The most commonly used criteria for DISH were designed to exclude radiographic signs of spondyloarthritis. However, case reports describing the presence of both conditions exist. In this study, the co-occurrence of AS and DISH were reviewed in the literature to explore the potential need to revise the criteria for DISH.
255. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review.
作者: Natalia Pittman.;Saara M Rawn.;Mianbo Wang.;Ariel Masetto.;Karen A Beattie.;Maggie Larché.
来源: Rheumatology (Oxford). 2018年57卷10期1802-1811页
Almost all patients with SSc have gastrointestinal manifestations. Small intestinal bacterial overgrowth (SIBO) occurs in 30-60% of patients and leads to malnutrition and impaired quality of life. Recent systematic reviews have reported efficacy of treatments for SIBO, but these are not specific to patients with SSc. We conducted a systematic review of the evidence for all possible SIBO treatments in the SSc population.
256. Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials.
作者: Monica S M Persson.;Aliya Sarmanova.;Michael Doherty.;Weiya Zhang.
来源: Rheumatology (Oxford). 2018年57卷10期1830-1837页
The role of inflammation in OA is controversial and it is unclear whether suppressing inflammation with conventional or biologic DMARDs is effective. A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to compare DMARDs with placebo in participants with symptomatic OA.
257. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis.
作者: Stephen J Duffield.;Natasha Miller.;Sizheng Zhao.;Nicola J Goodson.
来源: Rheumatology (Oxford). 2018年57卷8期1453-1460页
This systematic review and meta-analysis will describe the prevalence of concomitant FM in adults with inflammatory arthritis and quantify the impact of FM on DAS.
258. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies.
作者: Sharan K Rai.;Hyon K Choi.;Sally H J Choi.;Anne F Townsend.;Kam Shojania.;Mary A De Vera.
来源: Rheumatology (Oxford). 2018年57卷7期1282-1292页
Gout care remains highly suboptimal, contributing to an increased global disease burden. To understand barriers to gout care, our aim was to provide a systematic review and thematic synthesis of qualitative studies worldwide reporting provider and patient perspectives and experiences with management.
259. Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis.
To investigate the comparative efficacy, safety and tolerability of IL-6, IL-12/23 and IL-17 inhibitors for patients with active PsA.
|